Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting
Company to share new data on the use of AI-powered protein design to program T cell therapies for unprecedented efficacy in the treatment of solid tumors
Oops! Something went wrong while submitting the form.
May 18, 2023
Public Relations
Globe Newswire
Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)
Outpace Bio, a leader in protein design for cell therapy, announces presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
The Outpace Press Kit is designed to help journalists research Outpace. Please contact our communications team if you need more information or to schedule an interview.